Taking advantage of a broken patent system, Big Pharma is making minor tweaks to medications just to keep affordable generics off the market, a new report suggests. They’ve made billions of dollars in ...
Hosted on MSN
Tweak in NDCT rules soon to make drug testing simple
NEW DELHI: The Centre is set to amend the New Drugs and Clinical Trials (NDCT) Rules, 2019, to simplify requirements and procedures for obtaining test licenses and for submitting applications related ...
A new generation of malaria drugs failed clinical trials, in part because they were hard to swallow. UCSF chemists remodeled their structures to make them more soluble, while maintaining their ...
Established drugs were repurposed, “me-too” drugs were approved, and even the few new biological approaches lacked clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results